ArticleEncephalitis (Seoul, Korea)2021

Low-dose interleukin-2 as a novel therapeutic option for refractory paraneoplastic neurologic syndrome: a case of chronic relapsing anti-Ma2/Ta paraneoplastic myeloradiculopathy.

Seon-Jae Ahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.